2012-2018 年美国 中三苯甲基磺胺甲恶唑耐药模式。
Trimethoprim-sulfamethoxazole resistance patterns among in the United States, 2012-2018.
机构信息
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
Infect Control Hosp Epidemiol. 2023 May;44(5):794-797. doi: 10.1017/ice.2022.9. Epub 2022 Feb 15.
Abstract
We reviewed trimethoprim-sulfamethoxazole antibiotic susceptibility testing data among using 3 national inpatient databases. In all 3 databases, we observed an increases in the percentage of methicillin-resistant that were not susceptible to trimethoprim-sulfamethoxazole. Providers should select antibiotic regimens based on local resistance patterns and should report changes to the public health department.
摘要
我们回顾了使用 3 个国家住院患者数据库的甲氧苄啶-磺胺甲恶唑抗生素药敏试验数据。在所有 3 个数据库中，我们观察到对甲氧苄啶-磺胺甲恶唑不敏感的耐甲氧西林 的比例增加。医务人员应根据当地耐药模式选择抗生素方案，并向公共卫生部门报告变化情况。
相似文献
1
Trimethoprim-sulfamethoxazole resistance patterns among in the United States, 2012-2018.2012-2018 年美国 中三苯甲基磺胺甲恶唑耐药模式。
Infect Control Hosp Epidemiol. 2023 May;44(5):794-797. doi: 10.1017/ice.2022.9. Epub 2022 Feb 15.
2
Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.对从阿富汗喀布尔两家主要医疗机构的患者身上分离出的金黄色葡萄球菌菌株进行抗菌药敏模式测定。
BMC Infect Dis. 2017 Nov 29;17(1):737. doi: 10.1186/s12879-017-2844-4.
3
Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.社区相关性耐甲氧西林金黄色葡萄球菌的出现是否增加了甲氧苄啶-磺胺甲噁唑的使用和耐药性？一项 10 年时间序列分析。
Antimicrob Agents Chemother. 2012 Nov;56(11):5655-60. doi: 10.1128/AAC.01011-12. Epub 2012 Aug 20.
4
Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.儿童金黄色葡萄球菌感染中克林霉素和复方磺胺甲噁唑耐药性的增加。
J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351-353. doi: 10.1093/jpids/piy062.
5
Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting.对一种新出现的序列类型5耐甲氧西林金黄色葡萄球菌克隆株中甲氧苄啶/磺胺甲恶唑耐药性的调查揭示了耐药性报告的差异。
Clin Microbiol Infect. 2018 Sep;24(9):1027-1029. doi: 10.1016/j.cmi.2018.04.020. Epub 2018 May 1.
6
Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus.金黄色葡萄球菌中血红素诱导的复方磺胺甲噁唑异质性耐药表型检测。
Microbiol Spectr. 2021 Oct 31;9(2):e0151021. doi: 10.1128/Spectrum.01510-21. Epub 2021 Oct 27.
7
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.评价高剂量达托霉素联合复方磺胺甲噁唑治疗耐甲氧西林金黄色葡萄球菌（MRSA）感染的新型组合，该组合采用模拟心内膜赘生物的体外药代动力学/药效学模型。
Antimicrob Agents Chemother. 2012 Nov;56(11):5709-14. doi: 10.1128/AAC.01185-12. Epub 2012 Aug 20.
8
In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.甲氧苄啶-磺胺甲恶唑联合用药对耐甲氧西林金黄色葡萄球菌临床分离株的体外和体内疗效
Antimicrob Agents Chemother. 1986 Jun;29(6):1092-4. doi: 10.1128/AAC.29.6.1092.
9
Molecular evidence of β-lactam resistant Staphylococcus aureus in equids with respiratory tract infections: Frequency and resistance modulation strategy.马属动物呼吸道感染中耐β-内酰胺类金黄色葡萄球菌的分子证据：频率和耐药性调节策略。
Acta Trop. 2023 Sep;245:106967. doi: 10.1016/j.actatropica.2023.106967. Epub 2023 Jun 13.
引用本文的文献
1
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance.儿科患者的蜂窝织炎：耐药性不断演变时代的识别与管理
Am J Clin Dermatol. 2025 Apr 21. doi: 10.1007/s40257-025-00936-w.
2
Integrative omics analysis reveals insights into small colony variants of Staphylococcus aureus induced by sulfamethoxazole-trimethoprim.整合组学分析揭示了磺胺甲恶唑-甲氧苄啶诱导的金黄色葡萄球菌小菌落变异体的见解。
BMC Microbiol. 2024 Jun 14;24(1):212. doi: 10.1186/s12866-024-03364-8.
3
Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.门诊金黄色葡萄球菌分离株的抗菌药物耐药模式。
JAMA Netw Open. 2024 Jun 3;7(6):e2417199. doi: 10.1001/jamanetworkopen.2024.17199.
4
Overcoming antibiotic resistance: non-thermal plasma and antibiotics combination inhibits important pathogens.克服抗生素耐药性：非热等离子体与抗生素联合抑制重要病原体。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae007.
5
Antimicrobial Resistance, SCC, Virulence and Genotypes of MRSA in Southern China for 7 Years: Filling the Gap of Molecular Epidemiology.中国南方7年耐甲氧西林金黄色葡萄球菌的耐药性、葡萄球菌盒式染色体、毒力及基因型分析：填补分子流行病学空白
Antibiotics (Basel). 2023 Feb 10;12(2):368. doi: 10.3390/antibiotics12020368.
Zotero 插件